Supreme Court Continues to Build Out Its Framework for Patent Eligibility in High-Tech and Life Sciences Sectors
By BRUCE M. WEXLER & MAX H. YUSEM
Life Sciences Patent Litigation partner Bruce Wexler and associate Max Yusem discuss the Supreme Court’s recent Alice and Mayo decisions in context with a dissenting opinion by Federal Circuit Chief Judge Archer in Alappat, and they give practitioners advice on handling Section 101 patent eligibility issues accordingly.
This article was reproduced with permission from BNA’s Patent, Trademark & Copyright Journal, 88 PTCJ 784, 7/18/14. Copyright 2014 by The Bureau of National Affairs, Inc. (800-372-1033)